He has published his work in peer-reviewed medical journals.
HAMDEN, CT, August 08, 2022 /24-7PressRelease/ -- Professor Ashok K. Chakraborty, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
After earning a Bachelor of Science from the University of Calcutta, Dr. Chakraborty earned a master's degree from the same institution. He subsequently received a PhD in Pigment Cell Biology, breast cancer, and melanoma metastasis research through the University of Calcutta in 1980. Over the course of his career, he parlayed his expertise to others as an invited lecturer at Japanese universities, and as a research scientist and associate professor at Yale University, where he worked between 1989 and 2014 on Melanoma Biology, Pigment Cell Biology and Breast Cancer Drug Discovery.
Supported by his extensive experience, Dr. Chakraborty presently excels as a senior research analyst for AllExcel Inc. Over the years, he has contributed to more than 120 publications, including in Cancer Drug Discovery, Virology, and Neurodegenerative diseases. He has published his work in peer-reviewed medical journals of the American Association for Cancer Research, Melanoma Research and Breast Cancer Research and Treatment, Elsevier Publications and in Nature.
In order to remain aware of changes in the field, Dr. Chakraborty is affiliated with the Pan-American Society and the Dermatological Society and American Cancer Society. He is also the regular reviewer of several science journals, and in the Editorial Board of various peer-reviewed journals. While his career has been filled with highlights, he is most proud to have joined AllExcel, where he is working on neurodegenerative diseases, including Parkinson's Disease and Alzheimer's Disease, and also drug discovery for COVID-19, and Cancer. Since joining the organization, he has reprogrammed neural stem cells non-genetically and transplanted them into a rat PD model, which helped to revert disease symptoms and cognition defects. In the wake of the COVID-19 pandemic, he also began working on a new polymer-based nano-micelles antiviral regiment, which showed its dual activity to combat disease. Most of these works were already published as a Review and/or as a Research article in more than 20 peer-reviewed journals including Frontiers, Elsevier Publications.
Looking toward the future, Dr. Chakraborty intends to conduct a clinical trial for a Parkinson's disease treatment, as well as create a new cell line that can be used to treat diabetes.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #